Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature

Catharina Whybra, Eugen Mengel, Alexandra Russo, Franz Bahlmann, Christoph Kampmann, Michael Beck, Elke Eich, Eva Mildenberger, Catharina Whybra, Eugen Mengel, Alexandra Russo, Franz Bahlmann, Christoph Kampmann, Michael Beck, Elke Eich, Eva Mildenberger

Abstract

Background: Lysosomal storage disorders (LSD) are a rare cause of non immunological hydrops fetalis (NIHF) and congenital ascites. The reported incidence is about 1%. The incidence of idiopathic NIHF is estimated to be about 18%.

Patients and methods: We report four cases with transient hydrops fetalis resulting from LSD and performed a literature review on LSD with NIHF and congenital ascites in combination.

Results: At present, 12 different LSDs are described to be associated with NIHF or congenital ascites. Most patients had a family history of NIHF, where the preceding sibling had not been examined. A diagnostic approach to the fetus with NIHF due to suspected LSD either in utero or postnatal is suggested. Transient forms of NIHF and/or ascites in association with MPS IVA, MPS VII and NPC are described for the first time in this publication.

Conclusions: LSD should be considered in transient hydrops. Enzymatic studies in chorionic villous sample or amniotic cultured cells, once the most common conditions associated with fetal ascites or hydrops have been ruled out, are important. This paper emphasizes the fact that LSD is significantly higher than the estimated 1% in previous studies, which is important for genetic counseling as there is a high risk of recurrence and the availability of enzyme replacement therapy for an increasing number of LSD.

Figures

Figure 1
Figure 1
a: 22 weeks of gestation and massive hydrothorax in case II. b: 24 weeks of gestation, punction of hydrothorax and insertion of a thoraco-amniotic shunt in case II. Correct placement of the intrauterine shunt system. c: Regression of the hydrothorax at 31 weeks of gestation in case II.

References

    1. Randenberg AL. Nonimmune hydrops fetalis part I: etiology and pathophysiology. Neonatal Netw. 2010;29:281–295. doi: 10.1891/0730-0832.29.5.281.
    1. Castillo RA, Devoe LD, Hadi HA, Martin S, Geist D. Nonimmune hydrops fetalis: clinical experience and factors related to a poor outcome. Am J Obstet Gynecol. 1986;155:812–816.
    1. Sohan K, Carroll SG, De La Fuente S, Soothill P, Kyle P. Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment. Acta Obstet Gynecol Scand. 2001;80:726–730. doi: 10.1034/j.1600-0412.2001.080008726.x.
    1. Huang HR, Tsay PK, Chiang MC, Lien R, Chou YH. Prognostic factors and clinical features in liveborn neonates with hydrops fetalis. Am J Perinatol. 2007;24:33–38. doi: 10.1055/s-2006-958158.
    1. Bellini C, Hennekam RC. Non-immune hydrops fetalis: a short review of etiology and pathophysiology. Am J Med Genet A. 2012;158A:597–605. doi: 10.1002/ajmg.a.34438.
    1. Ayida GA, Soothill PW, Rodeck CH. Survival in non-immune hydrops fetalis without malformation or chromosomal abnormalities after invasive treatment. Fetal Diagn Ther. 1995;10:101–105. doi: 10.1159/000264214.
    1. Iskaros J, Jauniaux E, Rodeck C. Outcome of nonimmune hydrops fetalis diagnosed during the first half of pregnancy. Obstet Gynecol. 1997;90:321–325. doi: 10.1016/S0029-7844(97)00290-1.
    1. Swain S, Cameron AD, McNay MB, Howatson AG. Prenatal diagnosis and management of nonimmune hydrops fetalis. Aust N Z J Obstet Gynaecol. 1999;39:285–290. doi: 10.1111/j.1479-828X.1999.tb03398.x.
    1. Kattner E, Schafer A, Harzer K. Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease. Eur J Pediatr. 1997;156:292–295. doi: 10.1007/s004310050603.
    1. Wraith JE. Lysosomal disorders. Semin Neonatol. 2002;7:75–83. doi: 10.1053/siny.2001.0088.
    1. Burin MG, Scholz AP, Gus R, Sanseverino MT, Fritsh A, Magalhaes JA, Timm F, Barrios P, Chesky M, Coelho JC, Giugliani R. Investigation of lysosomal storage diseases in nonimmune hydrops fetalis. Prenat Diagn. 2004;24:653–657. doi: 10.1002/pd.967.
    1. Staretz-Chacham O, Lang TC, LaMarca ME, Krasnewich D, Sidransky E. Lysosomal storage disorders in the newborn. Pediatrics. 2009;123:1191–1207. doi: 10.1542/peds.2008-0635.
    1. Hutchison AA, Drew JH, Yu VY, Williams ML, Fortune DW, Beischer NA. Nonimmunologic hydrops fetalis: a review of 61 cases. Obstet Gynecol. 1982;59:347–352.
    1. Bonduelle M, Lissens W, Goossens A, De Catte L, Foulon W, Denis R, Jauniaux E, Liebaers I. Lysosomal storage diseases presenting as transient or persistent hydrops fetalis. Genet Couns. 1991;2:227–232.
    1. Denis R, Wayenberg JL, Vermeulen M, Gorus F, Gerlo E, Lissens W, Liebaers I, Jauniaux E, Vamos E. Hyperphosphatasemia in early diagnosed infantile GM1 gangliosidosis presenting as transient hydrops fetalis. Acta Clin Belg. 1996;51:320–327.
    1. Favre R, Dreux S, Dommergues M, Dumez Y, Luton D, Oury JF, Fiblec BL, Nisand I, Muller F. Nonimmune fetal ascites: a series of 79 cases. Am J Obstet Gynecol. 2004;190:407–412. doi: 10.1016/j.ajog.2003.09.016.
    1. Bellini C, Hennekam RC, Fulcheri E, Rutigliani M, Morcaldi G, Boccardo F, Bonioli E. Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet A. 2009;149A:844–851. doi: 10.1002/ajmg.a.32655.
    1. Bouvier R, Maire I. Diagnosis of lysosomal storage diseases with fetal presentation. Ann Pathol. 1997;17:277–280.
    1. Gillan JE, Lowden JA, Gaskin K, Cutz E. Congenital ascites as a presenting sign of lysosomal storage disease. J Pediatr. 1984;104:225–231. doi: 10.1016/S0022-3476(84)80997-X.
    1. Machin GA. Hydrops revisited: literature review of 1,414 cases published in the 1980s. Am J Med Genet. 1989;34:366–390. doi: 10.1002/ajmg.1320340313.
    1. Jauniaux E, Van Maldergem L, De Munter C, Moscoso G, Gillerot Y. Nonimmune hydrops fetalis associated with genetic abnormalities. Obstet Gynecol. 1990;75:568–572.
    1. Groener JE, de Graaf FL, Poorthuis BJ, Kanhai HH. Prenatal diagnosis of lysosomal storage diseases using fetal blood. Prenat Diagn. 1999;19:930–933. doi: 10.1002/(SICI)1097-0223(199910)19:10<930::AID-PD664>;2-X.
    1. Piraud M, Froissart R, Mandon G, Bernard A, Maire I. Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis) Clin Chim Acta. 1996;248:143–155. doi: 10.1016/0009-8981(95)06250-5.
    1. Kooper AJ, Janssens PM, de Groot AN, Liebrand-van Sambeek ML, van den Berg CJ, Tan-Sindhunata GB, van den Berg PP, Bijlsma EK, Smits AP, Wevers RA. Lysosomal storage diseases in non-immune hydrops fetalis pregnancies. Clin Chim Acta. 2006;371:176–182. doi: 10.1016/j.cca.2006.03.007.
    1. Mahony BS, Filly RA, Callen PW, Chinn DH, Golbus MS. Severe nonimmune hydrops fetalis: sonographic evaluation. Radiology. 1984;151:757–761.
    1. Abrams ME, Meredith KS, Kinnard P, Clark RH. Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death. Pediatrics. 2007;120:84–89. doi: 10.1542/peds.2006-3680.
    1. McFadden DE, Taylor GP. Cardiac abnormalities and nonimmune hydrops fetalis: a coincidental, not causal, relationship. Pediatr Pathol. 1989;9:11–17. doi: 10.3109/15513818909022328.
    1. Larroche JC, Aubry MC, Narcy F. Intrauterine brain damage in nonimmune hydrops fetalis. Biol Neonate. 1992;61:273–280. doi: 10.1159/000243754.
    1. Stone DL, Sidransky E. Hydrops fetalis: lysosomal storage disorders in extremis. Adv Pediatr. 1999;46:409–440.
    1. Norton ME. Nonimmune hydrops fetalis. Semin Perinatol. 1994;18:321–332.
    1. Alegria A, Martins E, Dias M, Cunha A, Cardoso ML, Maire I. Glycogen storage disease type IV presenting as hydrops fetalis. J Inherit Metab Dis. 1999;22:330–332. doi: 10.1023/A:1005568507267.
    1. Rodriguez MM, Bruce JH, Jimenez XF, Romaguera RL, Bancalari E, Garcia OL, Ferrer PL. Nonimmune hydrops fetalis in the liveborn: series of 32 autopsies. Pediatr Dev Pathol. 2005;8:369–378. doi: 10.1007/s10024-005-8089-z.
    1. Applegarth DA, Toone JR, Wilson RD, Yong SL, Baldwin VJ. Morquio disease presenting as hydrops fetalis and enzyme analysis of chorionic villus tissue in a subsequent pregnancy. Pediatr Pathol. 1987;7:593–599. doi: 10.3109/15513818709161423.
    1. Beck M, Braun S, Coerdt W, Merz E, Young E, Sewell AC. Fetal presentation of Morquio disease type A. Prenat Diagn. 1992;12:1019–1029. doi: 10.1002/pd.1970121207.
    1. Cheng Y, Verp MS, Knutel T, Hibbard JU. Mucopolysaccharidosis type VII as a cause of recurrent non-immune hydrops fetalis. J Perinat Med. 2003;31:535–537.
    1. Vervoort R, Islam MR, Sly WS, Zabot MT, Kleijer WJ, Chabas A, Fensom A, Young EP, Liebaers I, Lissens W. Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. Am J Hum Genet. 1996;58:457–471.
    1. Nelson A, Peterson L, Frampton B, Sly WS. Mucopolysaccharidosis VII (beta-glucuronidase deficiency) presenting as nonimmune hydrops fetalis. J Pediatr. 1982;101:574–576. doi: 10.1016/S0022-3476(82)80707-5.
    1. Colmant C, Picone O, Froissart R, Labrune P, Senat MV. Second-trimester diagnosis of mucopolysaccharidosis type IV a presenting as hydrops fetalis. Prenat Diagn. 2006;26:750–752. doi: 10.1002/pd.1467.
    1. Molyneux AJ, Blair E, Coleman N, Daish P. Mucopolysaccharidosis type VII associated with hydrops fetalis: histopathological and ultrastructural features with genetic implications. J Clin Pathol. 1997;50:252–254. doi: 10.1136/jcp.50.3.252.
    1. Van Dorpe J, Moerman P, Pecceu A, Van den Steen P, Fryns JP. Non-immune hydrops fetalis caused by beta-glucuronidase deficiency (mucopolysaccharidosis VII). Study of a family with 3 affected siblings. Genet Couns. 1996;7:105–112.
    1. Walter-Nicolet E, Rakza T, Storme L, Vaillant C, Magnenant E, Cremer R, Thumerelle C, Dobbelaere D. A new case of mucopolysaccharidosis VII presenting as non immune hydrops fetalis. Eur J Pediatr. 2003;162:520–521. doi: 10.1007/s00431-003-1198-7.
    1. Leticee N, Bessieres-Grattagliano B, Dupre T, Vuillaumier-Barrot S, de Lonlay P, Razavi F, El Khartoufi N, Ville Y, Vekemans M, Bouvier R. et al.Should PMM2-deficiency (CDG Ia) be searched in every case of unexplained hydrops fetalis? Mol Genet Metab. 2010;101:253–257. doi: 10.1016/j.ymgme.2010.06.009.
    1. van de Kamp JM, Lefeber DJ, Ruijter GJ, Steggerda SJ, den Hollander NS, Willems SM, Matthijs G, Poorthuis BJ, Wevers RA. Congenital disorder of glycosylation type Ia presenting with hydrops fetalis. J Med Genet. 2007;44:277–280. doi: 10.1136/jmg.2006.044735.
    1. Dursun A, Gucer S, Ebberink MS, Yigit S, Wanders RJ, Waterham HR. Zellweger syndrome with unusual findings: non-immune hydrops fetalis, dermal erythropoiesis and hypoplastic toe nails. J Inherit Metab Dis. 2009.
    1. Guibaud P, Cottin X, Maire I, Boyer S, Guibaud S, Coicaud C, Bellon-Azzouzi C, Duvernois JP. Fetal ascites as a manifestation of infantile sialidosis. Significance of a study of oligosaccharides in amniotic fluid. J Genet Hum. 1985;33:317–324.
    1. Godra A, Kim DU, D'Cruz C. Pathologic quiz case: a 5-day-old boy with hydrops fetalis. Mucolipidoses I (Sialidosis III) Arch Pathol Lab Med. 2003;127:1051–1052.
    1. Beck M, Bender SW, Reiter HL, Otto W, Bassler R, Dancygier H, Gehler J. Neuraminidase deficiency presenting as non-immune hydrops fetalis. Eur J Pediatr. 1984;143:135–139. doi: 10.1007/BF00445802.
    1. Landau D, Meisner I, Zeigler M, Bargal R, Shinwell ES. Hydrops fetalis in four siblings caused by galactosialidosis. Isr J Med Sci. 1995;31:321–322.
    1. Haverkamp F, Jacobs D, Cantz M, Hansmann M, Fahnenstich H, Zerres K. Nonimmune hydrops fetalis with galactosialidosis: consequences for family planning. Fetal Diagn Ther. 1996;11:114–119. doi: 10.1159/000264289.
    1. Tercanli S, Uyanik G, Hosli I, Cagdas A, Holzgreve W. Increased nuchal translucency in a case of long-chain 3-hydroxyacyl- coenzyme A dehydrogenase deficiency. Fetal Diagn Ther. 2000;15:322–325. doi: 10.1159/000021029.
    1. Tasso MJ, Martinez-Gutierrez A, Carrascosa C, Vazquez S, Tebar R. GM1-gangliosidosis presenting as nonimmune hydrops fetalis: a case report. J Perinat Med. 1996;24:445–449. doi: 10.1515/jpme.1996.24.5.445.
    1. Steenhout P, Elmer C, Clercx A, Blum D, Gnat D, van Erum S, Vertongen F, Vamos E. Carnitine deficiency with cardiomyopathy presenting as neonatal hydrops: successful response to carnitine therapy. J Inherit Metab Dis. 1990;13:69–75. doi: 10.1007/BF01799334.
    1. Maconochie IK, Chong S, Mieli-Vergani G, Lake BD, Mowat AP. Fetal ascites: an unusual presentation of Niemann-Pick disease type C. Arch Dis Child. 1989;64:1391–1393. doi: 10.1136/adc.64.10_Spec_No.1391.
    1. Manning DJ, Price WI, Pearse RG. Fetal ascites: an unusual presentation of Niemann-Pick disease type C. Arch Dis Child. 1990;65:335–336.
    1. Sun CC, Panny S, Combs J, Gutberlett R. Hydrops fetalis associated with Gaucher disease. Pathol Res Pract. 1984;179:101–104. doi: 10.1016/S0344-0338(84)80069-2.
    1. Lake BD, Young EP, Winchester BG. Prenatal diagnosis of lysosomal storage diseases. Brain Pathol. 1998;8:133–149.
    1. Maymon R, Ogle RF, Chitty LS. Smith-Lemli-Opitz syndrome presenting with persisting nuchal oedema and non-immune hydrops. Prenat Diagn. 1999;19:105–107. doi: 10.1002/(SICI)1097-0223(199902)19:2<105::AID-PD471>;2-W.
    1. Meizner I, Levy A, Carmi R, Robinsin C. Niemann-Pick disease associated with nonimmune hydrops fetalis. Am J Obstet Gynecol. 1990;163:128–129.
    1. Trajkovski Z, Vrcakovski M, Saveski J, Gucev ZS. Greenberg dysplasia (hydrops-ectopic calcification-moth-eaten skeletal dysplasia): prenatal ultrasound diagnosis and review of literature. Am J Med Genet. 2002;111:415–419. doi: 10.1002/ajmg.10578.
    1. Schafer A, Harzer K, Kattner E, Schafer HJ, Stoltenburg G, Lietz H. Disseminated lipogranulomatosis (Farber disease) with hydrops fetalis. Pathologe. 1996;17:145–149. doi: 10.1007/s002920050148.
    1. Straub W, Zarabi M, Mazer J. Fetal ascites associated with Conradi's disease (chondrodysplasia punctata): report of a case. J Clin Ultrasound. 1983;11:234–236. doi: 10.1002/jcu.1870110414.
    1. Poulain P, Odent S, Maire I, Milon J, Proudhon JF, Jouan H, Le Marec B. Fetal ascites and oligohydramnios: prenatal diagnosis of a sialic acid storage disease (index case) Prenat Diagn. 1995;15:864–867. doi: 10.1002/pd.1970150913.
    1. Lefebvre G, Wehbe G, Heron D, Vautjoer Brouzes D, Choukroun JB, Darbois Y. Recurrent nonimmune hydrops fetalis: a rare presentation of sialic acid storage disease. Genet Couns. 1999;10:277–284.
    1. Remes AM, Rantala H, Hiltunen JK, Leisti J, Ruokonen A. Fumarase deficiency: two siblings with enlarged cerebral ventricles and polyhydramnios in utero. Pediatrics. 1992;89:730–734.
    1. Coughlin EM, Christensen E, Kunz PL, Krishnamoorthy KS, Walker V, Dennis NR, Chalmers RA, Elpeleg ON, Whelan D, Pollitt RJ. et al.Molecular analysis and prenatal diagnosis of human fumarase deficiency. Mol Genet Metab. 1998;63:254–262. doi: 10.1006/mgme.1998.2684.
    1. Ben-Haroush A, Yogev Y, Levit O, Hod M, Kaplan B. Isolated fetal ascites caused by Wolman disease. Ultrasound Obstet Gynecol. 2003;21:297–298. doi: 10.1002/uog.73.
    1. Appelman Z, Blumberg BD, Golabi M, Golbus MS. Nonimmune hydrops fetalis may be associated with an elevated delta OD450 in the amniotic fluid. Obstet Gynecol. 1988;71:1005–1008.
    1. Valayannopoulos V, Verhoeven NM, Mention K, Salomons GS, Sommelet D, Gonzales M, Touati G, de Lonlay P, Jakobs C, Saudubray JM. Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease. J Pediatr. 2006;149:713–717. doi: 10.1016/j.jpeds.2006.08.016.
    1. Grubbs R, Vugrek O, Deisch J, Wagner C, Stabler S, Allen R, Baric I, Rados M, Mudd SH. S-adenosylhomocysteine hydrolase deficiency: two siblings with fetal hydrops and fatal outcomes. J Inherit Metab Dis. 2010;33:705–713. doi: 10.1007/s10545-010-9171-x.
    1. Pannier E, Viot G, Aubry MC, Grange G, Tantau J, Fallet-Bianco C, Muller F, Cabrol D. Congenital erythropoietic porphyria (Gunther's disease): two cases with very early prenatal manifestation and cystic hygroma. Prenat Diagn. 2003;23:25–30. doi: 10.1002/pd.491.
    1. Reissner K, Tayebi N, Stubblefield BK, Koprivica V, Blitzer M, Holleran W, Cowan T, Almashanu S, Maddalena A, Karson EM, Sidransky E. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus. Mol Genet Metab. 1998;63:281–288. doi: 10.1006/mgme.1998.2675.
    1. Soma H, Yamada K, Osawa H, Hata T, Oguro T, Kudo M. Identification of Gaucher cells in the chorionic villi associated with recurrent hydrops fetalis. Placenta. 2000;21:412–416. doi: 10.1053/plac.1999.0483.
    1. den Hollander NS, Kleijer WJ, Schoonderwaldt EM, Los FJ, Wladimiroff JW, Niermeijer MF. In-utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency. Ultrasound Obstet Gynecol. 2000;16:87–90. doi: 10.1046/j.1469-0705.2000.00148.x.
    1. Ramsay SL, Maire I, Bindloss C, Fuller M, Whitfield PD, Piraud M, Hopwood JJ, Meikle PJ. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases. Mol Genet Metab. 2004;83:231–238. doi: 10.1016/j.ymgme.2004.07.015.
    1. Schmidt M, Fahnenstich H, Haverkamp F, Platz H, Hansmann M, Bartmann P. Sialidosis and galactosialidosis as the cause of non-immunologic hydrops fetalis. Z Geburtshilfe Neonatol. 1997;201:177–180.
    1. Sergi C, Beedgen B, Kopitz J, Zilow E, Zoubaa S, Otto HF, Cantz M, Linderkamp O. Refractory congenital ascites as a manifestation of neonatal sialidosis: clinical, biochemical and morphological studies in a newborn Syrian male infant. Am J Perinatol. 1999;16:133–141. doi: 10.1055/s-2007-993847.
    1. Claeys M, Van der Hoeven M, de Die-Smulders C, Bakker JA, Offermans JP, Forget PP, Groener JE, Spaapen LJ. Early-infantile type of galactosialidosis as a cause of heart failure and neonatal ascites. J Inherit Metab Dis. 1999;22:666–667. doi: 10.1023/A:1005546501043.
    1. Uno Y, Taniguchi A, Tanaka E. Histochemical studies in Wolman's disease–report of an autopsy case accompanied with a large amount of milky ascites. Acta Pathol Jpn. 1973;23:779–790.
    1. Daneman A, Stringer D, Reilly BJ. Neonatal ascites due to lysosomal storage disease. Radiology. 1983;149:463–467.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren